Monodisperse PEG Linkers for Bioconjugation and Linker Design: OH-PEG8-OH and OH-PEG9-OH

OH-PEG8-OH and OH-PEG9-OH | Photo: Biopharma PEG Scientific Inc.

In the specialized fields of targeted therapeutics, nanoparticle surface modification, and advanced drug delivery systems, the structural integrity of crosslinking agents is a fundamental requirement. Traditional polydisperse polymers introduce variability in chain length, which complicates analytical characterization and can alter the pharmacokinetic profiles of the final bioconjugates. Monodisperse PEGs resolve this issue by providing exact molecular weights, ensuring predictable behavior and strict batch-to-batch consistency.

To support laboratory professionals, analytical chemists, and pharmaceutical developers, Biopharma PEG Scientific Inc. manufactures a specialized range of high-purity PEG derivatives. Among the most widely utilized in current bioconjugation research are the specific chain-length spacers OH-PEG8-OH and OH-PEG9-OH.

OH-PEG8-OH (Octaethylene Glycol)

CAS Number: 5117-19-1

• Structure
  A monodisperse, homobifunctional PEG featuring an eight-unit ethylene glycol chain terminated by stable, activatable hydroxyl groups.
• Applications
  OH-PEG8-OH serves as a foundational building block applied in peptide and protein PEGylation, the formulation of functionalized PEG hydrogels, and complex bioconjugation systems where exact spatial separation is required. Interestingly, octaethylene glycol is also identified as a component in certain botanical extracts currently researched for antimicrobial and anti-cancer properties.

OH-PEG9-OH (Nonaethylene Glycol)

CAS Number: 3386-18-3

• Structure
  Extending the spacer by a single repeating unit, this nine-unit PEG provides alternative physicochemical parameters for structural tuning.
• Applications
  Like the eight-unit variant, OH-PEG9-OH is a high-quality crosslinker for standard PEGylation. Additionally, it has proven highly effective in advanced delivery mechanisms, such as acting as a reactant in quantum-dot-based siRNA delivery systems designed for the selective inhibition of targeted tumor cells.

Analytical Rigor and Manufacturing Scalability

For procurement managers and R&D scientists, the quality of raw materials dictates the viability of the end product. Biopharma PEG Scientific Inc. provides high-purity monodisperse PEG linkers that are more than 98%. This rigorous purity threshold differentiates the materials from standard industry offerings, guaranteeing structural exactness during complex bioconjugation reactions.

Every batch undergoes comprehensive, orthogonal analytical testing, including NMR, (400 MHz), HPLC, MALDI-TOF MS, GC/LC, GC-MS, and LC-MS.

Beyond analytical precision, the transition from laboratory research to clinical production requires a robust supply chain. Operating under a strict Quality Management System (QMS), the facility supports GMP-grade manufacturing capabilities. This ensures that researchers have continuous, seamless access to highly uniform PEG derivatives from initial milligram-scale discovery phases through to multi-kilogram commercial production.